Skip to content

Author

Melek Karakurt Eryılmaz

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

Background Pathological complete response (pCR) after neoadjuvant therapy (NAT) is associated with long-term outcomes in breast cancer (BC). The remnant cholesterol inflammatory index (RCII) integrates lipid-related and inflammatory components, but its role in pCR prediction remains unclear. Methods This multicenter re...

Galip Can Uyar, Kadriye Başkurt, Ahmet Oruç et al. · 0 citations
Open access Oct 2026

Prognostic Value of Systemic Inflammation Markers and Clinical Factors in Grade 4 Diffuse Glioma: A Multicenter Retrospective Real-World Study

Background/Objectives: Systemic inflammation contributes to tumor growth and spread. We aimed to evaluate the association of pretreatment inflammatory indices and clinical and laboratory factors with survival in newly diagnosed grade 4 diffuse glioma. Methods: A total of 120 patients diagnosed with grade 4 diffuse glio...

Ece Ulukal Karancı, G. Emin, Ahmet Oruç et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.